Sclerosing Epithelioid Fibrosarcoma
5 clinical trials · Condition
◉ Watch Sclerosing Epithelioid Fibrosarcoma
| Record | Firm | Date |
|---|---|---|
| A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) (NCT05266196) | Salarius Pharmaceuticals, LLC | 2022-01-15 |
| Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group (NCT03967834) | Institut Claudius Regaud | 2021-04-26 |
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas (NCT03600649) | Salarius Pharmaceuticals, LLC | 2018-06-04 |
| Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery (NCT02180867) | National Cancer Institute (NCI) | 2014-08-12 |
Track Sclerosing Epithelioid Fibrosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.